Bedford, TX, United States of America

Laura Smith Lang


Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1996-1997

Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Laura Smith Lang in Ocular Disease Treatment**

Introduction

Laura Smith Lang is a notable inventor based in Bedford, TX. With an impressive record of two patents, her work primarily centers on advancements in the treatment of ocular diseases. Her dedication and ingenuity have made a significant impact in the field of pharmaceuticals.

Latest Patents

Laura's latest patents include innovative compounds that serve vital functions in treating ocular diseases. The first patent details the use of 5-methyl-isoxazole-4-carboxylic acid anilides, which play a crucial role in therapeutic applications. The second patent elaborates on the use of these compounds alongside 2-hydroxyethylidene-cyano acetic acid anilides for addressing ocular diseases with immune etiology. These innovations exemplify her commitment to improving healthcare outcomes for patients struggling with eye-related conditions.

Career Highlights

Laura is currently employed at Alcon Laboratories, Inc., a leading company in the eye care industry. Throughout her career, she has demonstrated remarkable technical skills and creativity, contributing to valuable research and development initiatives.

Collaborations

In her professional journey, Laura collaborates closely with her coworker, Stella M. Robertson. Together, they foster a dynamic working relationship that promotes innovation and addresses complex challenges within their field.

Conclusion

Laura Smith Lang's contributions as an inventor demonstrate her dedication to advancing treatments for ocular diseases. Her patents reflect a deep understanding of medicinal chemistry and a commitment to improving patient care. With ongoing research and collaboration, the impact of her work is poised to grow, offering new hope to those affected by eye diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…